Impact the Connection Between Adaptive Immunity and Systemic Lupus Erythematous

Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder of unknown etiology that mostly impact females. SLE illness is defined by the emergence of auto antibodies and the accumulation of immune complexes, leading to inflammation and tissue damage in multiple organs. Patients suffering from this condition may display pathological harm to several organs such as the kidneys, skin, joints, blood, or neurological system. Objectives: Our study aimed to carry out the role of the adaptive immunity including the main cells of adaptive immunity T cells, B cells, IL-6, IL-10 in the systemic lupus erythematous autoimmune disease. Main body: T lymphocytes immune tolerance. The breakdown is a crucial factor in the development of SLE and T lymphocytes perform a significant role in this pathway. It may result in triggering and stimulation of B lymphocytes and dendritic cells at sites of inflammation, as well as abnormal release of cytokines and cellular signaling. B lymphocytes in patients with SLE suffer from impaired regional and peripheral tolerance. Lupus arises from an abundance of self-reactive B lymphocytes that produce a variety of auto antibodies. Interactions between T cells and B cells are widely recognized. IL-6, a type of inflammatory cytokine, has been linked to the development of SLE in both mice and humans based on scientific research. IL-10 has been observed to have two distinct functions in SLE patients. It is a cytokine that reduces inflammation by preventing the production of other cytokines that promote inflammation, such as IFN-c. In addition, IL-10 plays a role in the B cell function, resulting in the growth and specialization of B cells, the switching of antibody classes, and the reduction of B cell mortality in germinal centers, so facilitating the creation of autoantibodies. Conclusion: The underlying mechanisms of SLE are not yet understood completely. Multiple predisposing factors are likely involved in the development of SLE and play a crucial role in triggering and sustaining aberrant immunological reactions. Nevertheless, the precise mechanism by which the disease develops is still not fully understood.

Authors

Publication Details

Journal
Journal of Clinical Surgery and Research
Published
2025-01-28
DOI
https://doi.org/10.31579/2768-2757/155
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact the Connection Between Adaptive Immunity and Systemic Lupus Erythematous

Fattma A. Ali
Journal of Clinical Surgery and Research
Systemic Lupus Erythematosus Research
article

Impact the Connection Between Adaptive Immunity and Systemic Lupus Erythematous

Fattma A. Ali
article en

Abstract

Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder of unknown etiology that mostly impact females. SLE illness is defined by the emergence of auto antibodies and the accumulation of immune complexes, leading to inflammation and tissue damage in multiple organs. Patients suffering from this condition may display pathological harm to several organs such as the kidneys, skin, joints, blood, or neurological system. Objectives: Our study aimed to carry out the role of the adaptive immunity including the main cells of adaptive immunity T cells, B cells, IL-6, IL-10 in the systemic lupus erythematous autoimmune disease. Main body: T lymphocytes immune tolerance. The breakdown is a crucial factor in the development of SLE and T lymphocytes perform a significant role in this pathway. It may result in triggering and stimulation of B lymphocytes and dendritic cells at sites of inflammation, as well as abnormal release of cytokines and cellular signaling. B lymphocytes in patients with SLE suffer from impaired regional and peripheral tolerance. Lupus arises from an abundance of self-reactive B lymphocytes that produce a variety of auto antibodies. Interactions between T cells and B cells are widely recognized. IL-6, a type of inflammatory cytokine, has been linked to the development of SLE in both mice and humans based on scientific research. IL-10 has been observed to have two distinct functions in SLE patients. It is a cytokine that reduces inflammation by preventing the production of other cytokines that promote inflammation, such as IFN-c. In addition, IL-10 plays a role in the B cell function, resulting in the growth and specialization of B cells, the switching of antibody classes, and the reduction of B cell mortality in germinal centers, so facilitating the creation of autoantibodies. Conclusion: The underlying mechanisms of SLE are not yet understood completely. Multiple predisposing factors are likely involved in the development of SLE and play a crucial role in triggering and sustaining aberrant immunological reactions. Nevertheless, the precise mechanism by which the disease develops is still not fully understood.

Journal of Clinical Surgery and ResearchVol. 6(1)
Openalex Percentile: Top 97%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.